CN1493287A - Shishan alkaloid drip pill and its preparation method - Google Patents

Shishan alkaloid drip pill and its preparation method Download PDF

Info

Publication number
CN1493287A
CN1493287A CNA03159199XA CN03159199A CN1493287A CN 1493287 A CN1493287 A CN 1493287A CN A03159199X A CNA03159199X A CN A03159199XA CN 03159199 A CN03159199 A CN 03159199A CN 1493287 A CN1493287 A CN 1493287A
Authority
CN
China
Prior art keywords
huperzine
preparation
coolant
polyethylene glycol
weight portion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA03159199XA
Other languages
Chinese (zh)
Inventor
进 钱
钱进
许军
彭红
李平
刘孝乐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanchang Hongyi Technology Co Ltd
Original Assignee
Nanchang Hongyi Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanchang Hongyi Technology Co Ltd filed Critical Nanchang Hongyi Technology Co Ltd
Priority to CNA03159199XA priority Critical patent/CN1493287A/en
Publication of CN1493287A publication Critical patent/CN1493287A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

A dripping pill of huperzine A and its superfine pulverizing process for preparing it are disclosed. Its advantages are high dissolving and disintegrating speed, high stripping percentage, quickly taking its effect, stability and low cost.

Description

Huperzine dropping pills and preparation method thereof
Technical field
The present invention relates to a kind of pharmaceutical product and preparation method thereof, specifically huperzine dropping pills and preparation method thereof.
Background technology
Huperzine A is a cholinesterase inhibitor, and true property ChE is had selective inhibitory, easily passes through blood brain barrier.Has the effect that promotes that memory represents and hypermnesis keep.
Zoopery shows that huperzine A oral absorbs rapidly and fully, and it is also fast to distribute, distribution phase half-life (t 1/2 α) be 9.8 minutes, the bioavailability height is drained slowly, eliminates phase half-life (t 1/2 β) be 247.5 minutes, mainly excrete with prototype and metabolite form by urine.The clinical benign memory deficits that are used for improve that the patient points to that memory, learning by association, image are recalled, random shape is re-recognized and ability such as portrait memory.The dysmnesia that dementia patients and brain organic pathological changes are caused also have the improvement effect.
The huperzine A oral formulation of list marketing at present has tablet and capsule.Because huperzine A is water insoluble, mildly bitter flavor has and draws moistly, and hydrophobicity is strong, huperzine A sheet or capsular disintegration time are long, dissolution and dissolution rate are low, absorption difference, and bioavailability is low, supplementary product consumption is big, child, old people, bed patient and dysphagia patients are taken inconvenience, and compliance is poor, have influenced the performance of huperzine A therapeutical effect.
The present invention makes the huperzine dropping pills agent by using ultramicro communication technique and dropping pill formulation Technology exactly, thereby overcomes huperzine A sheet and capsular above defective, and the therapeutical effect of huperzine A is given full play to.
Summary of the invention
The huperzine dropping pills of making by using ultramicro communication technique and dropping pill formulation Technology not only have disintegrate molten loose fast, dissolution and dissolution rate improve, steady quality, the pill volume is little, easy to carry and use, onset is rapid, compliance is good, be particularly suitable for the characteristics that child, old people, bed patient and dysphagia patients are taken, but also has working condition and production equipment is simple, production cost is low, compares the advantage that supplementary product consumption reduces with tablet or capsule, has demonstrated fully the new drug research exploitation spirit that people-oriented.
For achieving the above object, the present invention by the following technical solutions: 1 weight portion huperzine A and 50~200 weight portion carriers are added in 1~10 weight portion molten matrix through the fine powder of micronizing, fully mixing, dropping preparation method is condensed into ball in coolant, remove coolant, drying, promptly.
Among the present invention the chemical name of huperzine A be (5R, 9R, 11E)-5-amino-11-ethylidene-5,8,9,10-tetrahydrochysene-7-methyl-5,9-methylene cycloocta [b] pyridine-2-(1H)-ketone, molecular formula is C 15H 18N 2O, molecular weight are 242.32, and structural formula is
Carrier among the present invention includes but not limited to mannitol, lactose, sorbitol, xylitol, sucrose, fructose, glucose, maltose, aminoacid etc.
Substrate among the present invention includes but not limited to polyethylene glycol 6000, Macrogol 4000, polyethylene glycol 1500, cetomacrogol 1000, sodium stearate, glycerin gelatine, poloxamer, stearic acid, glycerol monostearate acid, insect wax etc.
Coolant among the present invention includes but not limited to dimethicone, liquid paraffin, vegetable oil, water, alcoholic solution etc.
Below through detecting to beneficial effect of the present invention as directed
One, detects index and method
1. disintegrate (molten loosing) time limit: check according to inspection technique disintegration (two appendix XA of Chinese Pharmacopoeia version in 2000).
2. dissolution rate: sample thief, according to dissolution method (two appendix XC of Chinese Pharmacopoeia version in 2000 three therapeutic methods of traditional Chinese medicine), with 0.01mol/L hydrochloric acid solution 100ml is solvent, rotating speed is that per minute 100 changes, operation in the time of 5,10,20,30 and 45 minutes, is got solution 1ml in accordance with the law, filter, filtrate is as need testing solution.Other precision takes by weighing through 80 ℃ of huperzine A reference substances that are dried to constant weight an amount of, makes the solution that contains 0.5 μ g among every 1ml, product solution in contrast with above-mentioned dissolve with hydrochloric acid solution and dilution.Get each 20 μ l of above-mentioned two kinds of solution respectively and inject chromatograph of liquid, according to high performance liquid chromatography (two appendix VD of Chinese Pharmacopoeia version in 2000), with octadecane silane group silica gel is filler, with methanol-water (50: 50, contain 0.2% triethylamine) is mobile phase, and flow velocity is 1.0ml/min, column temperature is 40 ℃, the detection wavelength is 310nm, measures peak area in accordance with the law, calculates stripping quantity by external standard method.
Two, commercially available huperzine A sheet testing result
1. disintegration time: 63 minutes
2. dissolution rate:
Time (minute) 5 10 20 30 45
Dissolution (%) 17.6 32.3 51.4 68.9 72.5
Three, example 1 sample detection result
1. the molten diffusing time: 3 minutes
2. dissolution rate:
Time (minute) 5 10 20 30 45
Dissolution (%) 49.4 68.5 92.3 98.7 99.2
Four, example 2 sample detection results
1. the molten diffusing time: 3 minutes
2. dissolution rate:
Time (minute) 5 10 20 30 45
Dissolution (%) 51.4 70.3 90.6 99.7 98.9
Five, example 3 sample detection results
1. the molten diffusing time: 4 minutes
2. dissolution rate:
Time (minute) 5 10 20 30 45
Dissolution (%) 48.3 69.2 88.4 98.9 98.6
Six, example 4 sample detection results
1. the molten diffusing time: 7 minutes
2. dissolution rate:
Time (minute) 5 10 20 30 45
Dissolution (%) 53.6 72.3 94.5 98.9 100.3
Seven, example 5 sample detection results
1. the molten diffusing time: 13 minutes
2. dissolution rate:
Time (minute) 5 10 20 30 45
Dissolution (%) 40.3 58.6 79.2 96.5 98.7
Eight, example 6 sample detection results
1. the molten diffusing time: 19 minutes
2. dissolution rate
Time (minute) 5 10 20 30 45
Dissolution (%) 41.5 52.6 77.4 93.5 98.7
The specific embodiment
One, example 1
Prescription:
Huperzine A 50mg
Mannitol 5g
Polyethylene glycol 6000 15g
Make 1000
Method for making: the micronizing of learning from else's experience is crossed the huperzine A of 200 mesh sieves and the mixing fine powders of mannitol is added in the fused polyethylene glycol 6000 substrate, stirs evenly, and with the dimethicone coolant, the dropping preparation method pill, drying, promptly.
Two, example 2
Prescription:
Huperzine A 50mg
Mannitol 5g
Macrogol 4000 15g
Make 1000
Method for making: the micronizing of learning from else's experience is crossed the huperzine A of 200 mesh sieves and the mixing fine powders of mannitol is added in the fused Macrogol 4000 substrate, stirs evenly, and with the dimethicone coolant, the dropping preparation method pill, drying, promptly.
Three, example 3
Prescription:
Huperzine A 50mg
Mannitol 5g
Polyethylene glycol 6000 5g
Macrogol 4000 10g
Make 1000
Method for making: the mixing fine powders that the micronizing of learning from else's experience is crossed the huperzine A of 200 mesh sieves and mannitol is added to fused Macrogol 4000 and the polyethylene glycol 6000 elder brother closes in the substrate, stirs evenly, and be coolant with the dimethicone, the dropping preparation method pill, drying, promptly.
Four, example 4
Prescription:
Huperzine A 50mg
Mannitol 5g
Glyceryl monostearate 15g
Make 1000
Method for making: the micronizing of learning from else's experience is crossed the huperzine A of 200 mesh sieves and the mixing fine powders of mannitol is added in the fused glyceryl monostearate substrate, and mixing is a coolant with the frozen water, the dropping preparation method pill, and drying, promptly.
Five, example 5
Prescription:
Huperzine A 50mg
Mannitol 5g
Polyethylene glycol 6000 10g
Poloxamer 5g
Make 1000
Method for making: the micronizing of learning from else's experience is crossed the huperzine A of 200 mesh sieves and the mixing fine powders of mannitol is added in fused polyethylene glycol 6000 and the poloxamer mixed-matrix, stirs evenly, and with the dimethicone coolant, the dropping preparation method pill, drying, promptly.
Six, example 6
Prescription:
Huperzine A 50mg
Mannitol 5g
Polyethylene glycol 6000 10g
Macrogol 4000 5g
Poloxamer 1g
Make 1000
Method for making: the micronizing of learning from else's experience is crossed the huperzine A of 200 mesh sieves and the mixing fine powders of mannitol is added in fused polyethylene glycol 6000, Macrogol 4000 and the poloxamer mixed-matrix, stirring evenly, is coolant with the dimethicone, the dropping preparation method pill, drying, promptly.

Claims (5)

1. huperzine dropping pills and preparation method thereof is characterized in that: 1 weight portion huperzine A and 50~200 weight portion carriers are added in 1~10 weight portion molten matrix through the mixing fine powders of micronizing, fully mixing, dropping preparation method is condensed into ball in coolant, remove coolant, drying, promptly.
2. the molecular formula of the described huperzine A of claim 1 is C 15H 18N 2O, molecular weight are 242.32, and structural formula is
Figure A0315919900021
3. the described carrier of claim 1 includes but not limited to mannitol, lactose, sorbitol, xylitol, sucrose, fructose, glucose, maltose, aminoacid etc.
4. the described substrate of claim 1 includes but not limited to polyethylene glycol 6000, Macrogol 4000, polyethylene glycol 1500, cetomacrogol 1000, sodium stearate, glycerin gelatine, poloxamer, stearic acid, glycerol monostearate acid, insect wax etc.
5. the described coolant of claim 1 includes but not limited to dimethicone, liquid paraffin, vegetable oil, water, alcoholic solution etc.
CNA03159199XA 2003-09-10 2003-09-10 Shishan alkaloid drip pill and its preparation method Pending CN1493287A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA03159199XA CN1493287A (en) 2003-09-10 2003-09-10 Shishan alkaloid drip pill and its preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA03159199XA CN1493287A (en) 2003-09-10 2003-09-10 Shishan alkaloid drip pill and its preparation method

Publications (1)

Publication Number Publication Date
CN1493287A true CN1493287A (en) 2004-05-05

Family

ID=34240935

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA03159199XA Pending CN1493287A (en) 2003-09-10 2003-09-10 Shishan alkaloid drip pill and its preparation method

Country Status (1)

Country Link
CN (1) CN1493287A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104352467A (en) * 2014-11-17 2015-02-18 辰欣药业股份有限公司 Huperzine A tablet and preparation method thereof
CN106822226A (en) * 2017-02-13 2017-06-13 惠州市九惠制药股份有限公司 A kind of peace stomach ulcer sustained-release dropping pill and preparation method for treating stomach and duodenal bulbar ulcer

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104352467A (en) * 2014-11-17 2015-02-18 辰欣药业股份有限公司 Huperzine A tablet and preparation method thereof
CN106822226A (en) * 2017-02-13 2017-06-13 惠州市九惠制药股份有限公司 A kind of peace stomach ulcer sustained-release dropping pill and preparation method for treating stomach and duodenal bulbar ulcer

Similar Documents

Publication Publication Date Title
CN1493287A (en) Shishan alkaloid drip pill and its preparation method
CN1493298A (en) Ginseng stem leaf total saponin drip pill and its preparation method
CN1528321A (en) Rhizoma gastrodiae extract drop pill and preparing method thereof
CN1490001A (en) Hepadestal drops and preparation thereof
CN1528287A (en) Herba lysionoti extract drop pill and preparing method thereof
CN1562001A (en) Carbazochrome sodium sulfoate dripping pill and its preparing method
CN1582908A (en) Tramadol hydrochloride drops and their preparation
CN1582943A (en) Clomipramine hydrochloride drops and their preparation
CN1568987A (en) Dripping pills of paroxetine hydrochloride and its preparation method
CN1546022A (en) Dripping pills of luteanine hydrochloride and its preparation
CN1528296A (en) Pilocarpine nitrate drop pill and preparing method thereof
CN1528272A (en) Agrimophol drop pill and preparing method thereof
CN1526393A (en) Hydralazine hydrochloride guttate pills and the prepn
CN1568948A (en) Venlafaxine hydrochloride drop pills and preparation method thereof
CN1602848A (en) Ambroxol hydrochloride drop pills and its preparation method
CN1602860A (en) Dripping pills of clemastine fumarate and its preparation method
CN1543949A (en) Dripping pills of isopropiram fumaratis and its preparation
CN1528294A (en) Indolol drop pill and preparing method thereof
CN1493276A (en) Ferulaic acid sodium drip pill and its preparation method
CN1493290A (en) Ferulaic acid piperazine drip pill and its preparation method
CN1489995A (en) Amitriptyline hydrochloride drops and preparation thereof
CN1493288A (en) Hanfangchin A drip pill and its preparation method
CN1568979A (en) Dripping pills of lofexidine hydrochloride and its preparation method
CN1582940A (en) Calmazine hydrochloride drops and their preparation
CN1602868A (en) Dripping pills of ketotifen fumarate and its preparation method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication